WILLWAY GLOBAL, LLC is an executive search firm which partners with Pharmaceutical, Medical Device, Life Sciences and Healthcare organizations. We have been serving best in class organizations for 20 years' within 7 continents worldwide. WILLWAY GLOBAL's talent acquisition reach spans across all Corporate Verticals, R&D, Commercial, Consulting, RPO and Startups ranging from $500 Million to $50 Billion organizations. As a woman owned and fully operated organization, WILLWAY GLOBAL is also a proud member of the HBA (Healthcare Business Women’s Association).

YOUR TRUE
PARTNER.

As an organization which understands your needs, while operating as an extension of your team, WILLWAY GLOBAL brings over 15 years of in-house, corporate talent acquisition expertise, in addition to executive search expertise.

OUR PHILOSOPHY DRIVES OUR SEARCH.

A philosophy and mindset adopted by patients, leaders and innovators, centered around a simple concept with high impact. “Where there's a will, there's a way”. This philosophy not only drives our organization, it also transcends into each partnership. 

DELIVERING THE
RIGHT TALENT.

Creating long lasting, on target relationships is what we do. We deliver the right talent the first time. Leveraging behavioral based interview assessment methods, creating deep partnerships which foster a transparent, inclusive environment and driving a positive impact on the people around us is a direct correlation to solving your organizational needs. 

Continents Served Worldwide

EXECUTIVE & LEADERSHIP PLACEMENT

TECHNOLOGY IMPLEMENTATIONS

PROGRAM
DEVELOPMENT

PHARMACEUTICAL

The U.S. Pharmaceutical Industry is one of the world’s most significant national markets holding 30-40 percent of the worldwide market. In 2016, this share was valued at approximately $446 billion U.S. dollars.  Currently, the industry is at an important juncture. Developing remarkable new medicines, preparing for demand and navigating barriers to free trade, is even more critical for organizations and their executives today.

LIFE SCIENCES

All Life Sciences industry growth is closely tied to global healthcare expenditures.

Biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, cosmeceuticals, and environmental populations are heavily impacted by pricing pressures, regulatory changes, and emerging innovations. Adapting to potential downstream impacts and uncertainty in the regulatory landscape, will continue to be imperative priorities for executives managing these outcomes.

MEDICAL DEVICE

The Medical Device industry is a $390 billion market and will continue to grow in 2017, however cost cutting efforts will be an opportunity for organizations and their leaders. The wearable device revenues will outpace the remainder of the medical device market, while cybersecurity threats will become more of a concern. Strong leadership implementing fully optimized offerings and scalable M&A decisions will also continue to be a growing need within this industry.

HEALTHCARE

The US is a $9.59 trillion global healthcare market in both developed and developing nations. With rising healthcare cost, gaps in service and increasing demand for wellness, new providers and virtual care is on the rise. Bringing continued care to patients and innovative talent within this segment will result in favorable outcomes. The longer-term impact within this everchanging industry will be shaped by its leaders as they create more value for patients, healthcare payers and providers.